*Department of Ophthalmology, New England Eye Center and Tufts Medical Center, Tufts University, Boston, MA;
†Department of Electrical Engineering and Computer Science, and Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA; and
‡CAPES Foundation, Ministry of Education of Brazil, Brasilia, Brazil.
Reprint requests: Nadia K. Waheed, MD, MPH, New England Eye Center at Tufts Medical Center, 260 Tremont Street, Biewend Building, 9–11th Floor, Boston, MA 02116; e-mail: [email protected]
Supported in part by the Massachusetts Lions Clubs. J. S. Duker is a consultant for and receives research support from Carl Zeiss Meditec, OptoVue, and Topcon Medical Systems Inc.; and has stock in Hemera Biosciences Inc., EyeNetra, and Ophthotech Corp. N. K. Waheed was a consultant for Iconic therapeutics, served the speaker's bureau for Thrombogenics, and receives research support from Carl Zeiss Meditec. C. R. Baumal is a consultant for Allergan and received a travel grant from Optovue.
Presented at the American Academy of Ophthalmology, November 2015, Las Vegas, Nevada.
None of the authors have any conflicting interests to disclose.